The patent applications for the pharmaceutical composition for treating TRPV1 activity-mediated diseases have been completed in Japan and China.
Title of Invention
Pharmaceutical composition for treating TRPV1 activity-mediated diseases
Japan Application Number
(Not yet assigned)
China Application Number 2020800866718Filing Date
(International Filing Date)
2020. 12. 22.
Applicant
RudaCure Co., Ltd.
Inventors
Yongho Kim, Seunghoon Kim, Hawon Jeon, Yuseung Ha
Priority
Korean patent application 10-2020-0007433, filed January 20, 2020
Request for Examination
2022. 9. 16.
National Phase Entry Date
2022. 7. 19.
International Application Number
PCT/KR2020/018895
International Publication Number
WO 2021/149925 A1
The requests for examination were filed simultaneously on September 16th, and we will announce again upon registration.